Small Molecule And High Potent API

Custom API manufacturing services support late‑stage clinical and commercial programs requiring flexibility across scale, potency, and process complexity. Facilities in the United States and Europe enable a wide range of batch sizes and reactor volumes, accommodating both small molecule and high‑potency compounds.

Manufacturing capabilities include diverse unit operations such as hydrogenation, carbonylation, crystallization, centrifugation, drying, milling, and chromatography, allowing production trains to be configured for individual processes. Dedicated technical teams provide process transfer, familiarization, optimization, troubleshooting, and validation support, helping ensure robust and reproducible manufacturing outcomes.

Comprehensive analytical services span method development, transfer, validation, raw material testing, final release, and ICH stability programs, supported by advanced chromatography, spectroscopy, and materials characterization techniques. When combined with integrated downstream drug product manufacturing options, these capabilities help streamline development, reduce handoffs, and support a reliable, end‑to‑end pathway from API production through finished dosage form readiness.